| Year |
Citation |
Score |
| 2019 |
Chilcoat HD, Amick HR, Sherwood MR, Dunn KE. Buprenorphine in the United States: Motives for abuse, misuse, and diversion. Journal of Substance Abuse Treatment. 104: 148-157. PMID 31370979 DOI: 10.1016/J.Jsat.2019.07.005 |
0.31 |
|
| 2017 |
DeVeaugh-Geiss A, Chilcoat H, Coplan P, Harikrishnan V, Besharat AC, Green JL. Monitoring Internet postings for mentions of an extended-release hydrocodone formulation with abuse-deterrent properties Drug and Alcohol Dependence. 171: e54. DOI: 10.1016/J.Drugalcdep.2016.08.159 |
0.356 |
|
| 2017 |
Chilcoat H, Coplan P, Sessler N, Harikrishnan V. Changes in nonmedical use of OxyContin after reformulation with abuse deterrent properties Drug and Alcohol Dependence. 171: e41. DOI: 10.1016/J.Drugalcdep.2016.08.125 |
0.343 |
|
| 2016 |
Janoff SL, Perrin NA, Coplan PM, Chilcoat HD, Campbell CI, Green CA. Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties. Bmc Pharmacology & Toxicology. 17: 21. PMID 27177423 DOI: 10.1186/s40360-016-0064-y |
0.325 |
|
| 2016 |
Coplan PM, Chilcoat HD, Butler SF, Sellers EM, Kadakia A, Harikrishnan V, Haddox JD, Dart RC. The Effect of an Abuse-Deterrent Opioid Formulation on Opioid Abuse-Related Outcomes in the Post-Marketing Setting. Clinical Pharmacology and Therapeutics. PMID 27170195 DOI: 10.1002/Cpt.390 |
0.443 |
|
| 2015 |
DeVeaugh-Geiss A, Kadakia A, Chilcoat H, Alexander L, Coplan P. A retrospective cohort study of long-term immediate-release hydrocodone/acetaminophen use and acetaminophen dosing above the Food and Drug Administration recommended maximum daily limit among commercially insured individuals in the United States (2008-2013). The Journal of Pain : Official Journal of the American Pain Society. 16: 569-79.e1. PMID 25827064 DOI: 10.1016/J.Jpain.2015.03.004 |
0.336 |
|
| 2015 |
Chilcoat H, Coplan P, Sessler N, Harikrishnan V. Changes in age-specific rates of doctor-shopping for opioids following introduction of reformulated Oxycontin ® tablets Drug and Alcohol Dependence. 156: e42. DOI: 10.1016/J.Drugalcdep.2015.07.1033 |
0.325 |
|
| 2015 |
Sandstrom LE, Coplan P, Chilcoat H, Brason FW, Leukefeld C, Morris LA. Brief guide to prevent overdose fatality for prescription opioid abusers: A harm reduction initiative Drug and Alcohol Dependence. 146: e89. DOI: 10.1016/J.Drugalcdep.2014.09.610 |
0.385 |
|
| 2015 |
Havens JR, DeVeaugh-Geiss A, Leukefeld C, Kale H, Coplan P, Chilcoat H. Routes of administration and frequency of abuse of OxyContin® and immediate-release oxycodone in a rural kentucky county following introduction of reformulated OxyContin: Results from the first 71 follow-up interviews Drug and Alcohol Dependence. 146: e138. DOI: 10.1016/J.Drugalcdep.2014.09.294 |
0.353 |
|
| 2015 |
DeVeaugh-Geiss A, Coplan P, Kadakia A, Chilcoat H. Is opioid dose a strong predictor of the risk of opioid overdose? Important confounding factors that change the dose–overdose relationship Drug and Alcohol Dependence. 146: e265. DOI: 10.1016/J.Drugalcdep.2014.09.186 |
0.394 |
|
| 2014 |
Sessler NE, Downing JM, Kale H, Chilcoat HD, Baumgartner TF, Coplan PM. Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation. Pharmacoepidemiology and Drug Safety. 23: 1238-46. PMID 24916486 DOI: 10.1002/pds.3658 |
0.315 |
|
| 2014 |
McNaughton EC, Coplan PM, Black RA, Weber SE, Chilcoat HD, Butler SF. Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse. Journal of Medical Internet Research. 16: e119. PMID 24800858 DOI: 10.2196/jmir.3397 |
0.308 |
|
| 2014 |
Havens JR, Leukefeld CG, DeVeaugh-Geiss AM, Coplan P, Chilcoat HD. The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers. Drug and Alcohol Dependence. 139: 9-17. PMID 24721614 DOI: 10.1016/j.drugalcdep.2014.02.018 |
0.345 |
|
| 2014 |
Chilcoat H, Coplan P, Sessler N, Schulz B, Yuan Y. (138) Impact of an opioid reformulation with abuse-deterrent properties on doctor-shopping The Journal of Pain. 15: S10. DOI: 10.1016/J.Jpain.2014.01.044 |
0.378 |
|
| 2014 |
Willis J, Chilcoat H. Changes in the age distribution of admissions to substance abuse treatment for opioid abuse in the U.S. from 2000 to 2010 Drug and Alcohol Dependence. 140: e243. DOI: 10.1016/J.Drugalcdep.2014.02.672 |
0.396 |
|
| 2014 |
Erensen JG, Haddox JD, Chilcoat H. Identification of data gaps that preclude evidence-based drug control policies aimed at reducing opioid analgesic abuse Drug and Alcohol Dependence. 140: e55. DOI: 10.1016/J.Drugalcdep.2014.02.170 |
0.361 |
|
| 2014 |
DeVeaugh-Geiss A, Leukefeld C, Havens JR, Coplan P, Kale H, Chilcoat H. Abuse of OxyContin® and immediate-release oxycodone in a rural Kentucky county following introduction of reformulated OxyContin: Results from 6-month follow-up interviews Drug and Alcohol Dependence. 140: e46. DOI: 10.1016/J.Drugalcdep.2014.02.146 |
0.418 |
|
| 2014 |
Biondo G, Chilcoat H. Changing patterns of onset of nonmedical prescription opioid use relative to other drugs from adolescence to early adulthood Drug and Alcohol Dependence. 140: e14-e15. DOI: 10.1016/J.Drugalcdep.2014.02.061 |
0.389 |
|
| 2013 |
Coplan PM, Kale H, Sandstrom L, Landau C, Chilcoat HD. Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics. Pharmacoepidemiology and Drug Safety. 22: 1274-82. PMID 24123484 DOI: 10.1002/pds.3522 |
0.32 |
|
| 2013 |
Severtson SG, Bartelson BB, Davis JM, Muñoz A, Schneider MF, Chilcoat H, Coplan PM, Surratt H, Dart RC. Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. The Journal of Pain : Official Journal of the American Pain Society. 14: 1122-30. PMID 23816949 DOI: 10.1016/J.Jpain.2013.04.011 |
0.358 |
|
| 2013 |
Butler SF, Cassidy TA, Chilcoat H, Black RA, Landau C, Budman SH, Coplan PM. Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. The Journal of Pain : Official Journal of the American Pain Society. 14: 351-8. PMID 23127293 DOI: 10.1016/J.Jpain.2012.08.008 |
0.42 |
|
| 2013 |
Coplan P, Wentworth C, Downing J, Chilcoat H, Sessler N. Comparison of overdose rates among patients prescribed buprenorphine patch, fentanyl, patch and morphine in the UK The Journal of Pain. 14: S82. DOI: 10.1016/J.Jpain.2013.01.667 |
0.321 |
|
| 2013 |
Coplan P, Wentworth C, Downing J, Chilcoat H, Sessler N. The risk of opioid overdose among patients receiving higher versus lower doses of extended-release opioids in the UK The Journal of Pain. 14: S18. DOI: 10.1016/J.Jpain.2013.01.080 |
0.367 |
|
| 2012 |
Chilcoat H, Bucher Bartelson B, Coplan P, Dart R, Davis J, Green J, Muñoz A, Schneider MF, Severtson S, Surratt H. Poster 282 Changes in Diversion Rates Following the Introduction of a Reformulated Extended-Release Oxycodone Product Pm&R. 4: S285-S285. DOI: 10.1016/J.Pmrj.2012.09.895 |
0.31 |
|
| 2012 |
Coplan P, Chilcoat H, Kale H, Sandstrom L. Poster 104 Changes in Calls to Poison Centers for Oxycodone and Heroin After Introduction of a Reformulated Extended-Release Oxycodone Tablet Pm&R. 4: S225-S225. DOI: 10.1016/J.Pmrj.2012.09.729 |
0.328 |
|
| 2012 |
Chilcoat H, Bartelson BB, Coplan P, Dart R, Davis J, Green J, Muñoz A, Schneider MF, Severtson S. Poster 99 Difference in Rates of Abuse Following Reformulation of Extended Release Oxycodone Using Data from the Radars® System Poison Center Program Pm&R. 4: S223-S223. DOI: 10.1016/J.Pmrj.2012.09.724 |
0.349 |
|
| 2012 |
Coplan P, Kale H, Sandstom L, Chilcoat H. Effects of reformulated OxyContin® on opioid abuse in the National Poison Data System The Journal of Pain. 13. DOI: 10.1016/J.Jpain.2012.01.345 |
0.381 |
|
| 2012 |
Davis J, Severtson S, Bartelson B, Munoz A, Schneider M, Surratt H, Coplan P, Chilcoat H, Green J, Dart R. 93 Changes in Diversion Rates Following the Introduction of a Reformulated Extended Release Oxycodone Product Annals of Emergency Medicine. 60: S35. DOI: 10.1016/J.Annemergmed.2012.06.372 |
0.31 |
|
| 2012 |
Severtson S, Bartelson B, Davis J, Munoz A, Schneider M, Coplan P, Chilcoat H, Green J, Dart R. 92 Difference in Rates of Abuse Following Reformulation of Extended Release Oxycodone Using Data From the RADARS® System Poison Center Program Annals of Emergency Medicine. 60: S34-S35. DOI: 10.1016/J.Annemergmed.2012.06.371 |
0.349 |
|
| 2007 |
Ramchand R, Ialongo NS, Chilcoat HD. The effect of working for pay on adolescent tobacco use. American Journal of Public Health. 97: 2056-62. PMID 17901448 DOI: 10.2105/Ajph.2006.094045 |
0.468 |
|
| 2007 |
Miech R, Chilcoat H. The formation of a socioeconomic disparity: a case study of cocaine and marijuana use in the 1990s. American Journal of Preventive Medicine. 32: S171-6. PMID 17543708 DOI: 10.1016/J.Amepre.2007.02.021 |
0.31 |
|
| 2006 |
Velez ML, Montoya ID, Jansson LM, Walters V, Svikis D, Jones HE, Chilcoat H, Campbell J. Exposure to violence among substance-dependent pregnant women and their children. Journal of Substance Abuse Treatment. 30: 31-8. PMID 16377450 DOI: 10.1016/J.Jsat.2005.09.001 |
0.317 |
|
| 2005 |
Miech RA, Chilcoat H, Harder VS. The increase in the association of education and cocaine use over the 1980s and 1990s: evidence for a 'historical period' effect. Drug and Alcohol Dependence. 79: 311-20. PMID 16102375 DOI: 10.1016/J.Drugalcdep.2005.01.022 |
0.312 |
|
| 2005 |
Miech R, Chilcoat H. Maternal education and adolescent drug use: a longitudinal analysis of causation and selection over a generation. Social Science & Medicine (1982). 60: 725-35. PMID 15571891 DOI: 10.1016/J.Socscimed.2004.06.025 |
0.32 |
|
| Show low-probability matches. |